Slides and webcasts from all ESMO Advanced courses are open to all, ESMO Members and free ESMO Account holders, according to the presenters' agreement to release them.
ESMO thanks the authors for their generosity.
ESMO Virtual Advanced Course on EGFR-Mutated NSCLC 2021
- Start date
- 21 Jun 2021
- End date
- 23 Jun 2021
- Location
- Virtual, GMT +8
Learning objectives
- Understanding the biology of EGFR in normal and malignant cells
- Gaining insights in the spectrum of EGFR activating mutations, platforms, and strategies for molecular testing
- Understanding the role of biomarkers in selecting NSCLC patients for EGFR TKIs
- Discussing state-of-the-art therapeutic strategies and clinical research in EGFR mutated NSCLC
- Managing toxicity and how to use EGFR TKIs in specific subgroups of patients
Accreditation
The programme of this virtual event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Pasi A. Jänne, United States
- Tony S. K. Mok, Hong Kong
- Solange Peters, Switzerland
Supported by
